Connect with us:
CURRENT ISSUE
January 2025
January 2025
Bethany T. Samuelson Bannow, MD, MCR
Dr. Samuelson Bannow discusses the ways in which individuals assigned female at birth and pregnant individuals are still excluded from many clinical trials.
January 2025
The multicenter, randomized, open-label phase III study MajesTEC4/EMN30 aims to improve durability of response in patients with newly diagnosed multiple myeloma (NDMM) by pairing teclistamab, a B-cell maturation antigen x CD3 bispecific antibody, with lenalidomide, the current standard of care for maintenance in this population.
January 2025
Time-limited treatment with ibrutinib plus venetoclax in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) guided by measurable residual disease (MRD) significantly improves quality of life for these patients, including mitigating fatigue.
January 2025
Data presented at a poster session of the 66th American Society of Hematology Annual Meeting and Exposition suggest that creatinine-based equations to estimate glomerular filtration rate (eGFR) may outperform cystatin C-based equations when evaluating patients with sickle cell disease (SCD) for kidney disease, but follow-up is needed.
